The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $63.07

Today's change+0.25 +0.40%
Updated September 30 4:01 PM EDT. Delayed by at least 15 minutes.
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $63.07

Today's change+0.25 +0.40%
Updated September 30 4:01 PM EDT. Delayed by at least 15 minutes.

AbbVie Inc crosses above 125-day moving average

AbbVie Inc closed up Friday by (U.S.)$0.25 or 0.40% to (U.S.)$63.07 and crossing above its 125-day moving average. Shares have lost 2.94% over the last five days, but have gained 6.47% over the last year to date. This security has outperformed the S&P 500 by 2.99% during the last year.

Key company metrics

  • Open(U.S.) $62.67
  • Previous close(U.S.) $62.82
  • High(U.S.) $63.26
  • Low(U.S.) $62.45
  • Bid / Ask(U.S.) $62.86 / (U.S.) $63.25
  • YTD % change+6.47%
  • Volume7,316,537
  • Average volume (10-day)6,468,178
  • Average volume (1-month)6,769,059
  • Average volume (3-month)7,553,848
  • 52-week range(U.S.) $45.45 to (U.S.) $68.12
  • Beta1.51
  • Trailing P/E18.08×
  • P/E 1 year forward13.06×
  • Forward PEG0.80×
  • Indicated annual dividend(U.S.) $2.28
  • Dividend yield3.62%
  • Trailing EPS(U.S.) $3.49
Updated September 30 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.19%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue6,4525,9586,4005,944
Total other revenue--------
Total revenue6,4525,9586,4005,944
Gross profit5,0294,6274,9254,866
Total cost of revenue1,4231,3311,4751,078
Total operating expense4,0653,6804,2874,059
Selling / general / administrative1,4661,3551,7371,474
Research & development1,1249461,0751,418
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)704900
Other operating expenses, total----00
Operating income2,3872,2782,1131,885
Interest income (expense), net non-operating245-215-208-207
Gain (loss) on sale of assets--------
Other--------
Income before tax2,0961,7761,9241,647
Income after tax1,6101,3541,5171,239
Income tax, total486422407408
Net income1,6101,3541,5171,239
Total adjustments to net income--------
Net income before extra. items1,6101,3541,5171,239
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,6101,3541,5171,239
Inc. avail. to common incl. extra. items1,6101,3541,5171,239
Diluted net income1,6101,3541,5171,239
Dilution adjustment--------
Diluted weighted average shares1,6321,6251,6431,664
Diluted EPS excluding extraordinary itemsvalue per share0.990.830.920.74
Dividends per sharevalue per share0.570.570.570.51
Diluted normalized EPSvalue per share1.030.860.920.74